Results 281 to 290 of about 83,920 (307)

Translational advances in pancreatic ductal adenocarcinoma therapy

Nature Cancer, 2022
Abdel Hosein, Stephanie K Dougan, Andrew J Aguirre   +2 more
exaly  

Standard for the Management of Ductal Carcinoma In Situ of the Breast (DCIS)

Ca-A Cancer Journal for Clinicians, 2002
Monica Morrow
exaly  

Challenges in ductal carcinoma in situ risk communication and decision‐making

Ca-A Cancer Journal for Clinicians, 2012
Ann H Partridge
exaly  

PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC

Signal Transduction and Targeted Therapy, 2020
Xunbin Wei, Shengyu Yang, Jihui Hao
exaly  

Invasive Ductal Carcinomas

2011
Sophia Kim Apple, Lawrence W. Bassett, Cheryce M. Poon   +2 more
openaire   +1 more source

Invasive Ductal Carcinoma

2011
openaire   +1 more source

Cancer statistics: Breast cancer in situ

Ca-A Cancer Journal for Clinicians, 2015
Otis W Brawley
exaly  

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma

Nature Reviews Cancer, 2010
Sam C Wang, Matthias Hebrok
exaly  

Acinar cell plasticity and development of pancreatic ductal adenocarcinoma

Nature Reviews Gastroenterology and Hepatology, 2017
Peter Storz
exaly  

Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma

Cancer Cell, 2012
Paolo P Provenzano, Sunil R Hingorani
exaly